Luebecker Onkologische Schwerpunktpraxis

The trials here

What the 3 trials at this site are about, from their registry records.

Conditions

• Chronic lymphocytic leukaemia1 trial
• Colorectal cancer1 trial
• Myeloproliferative neoplasms1 trial

Phase

• Phase 32 trials
• Phase 41 trial

Status

• Active, not recruiting2 trials
• Completed1 trial

Lead sponsor

• GlaxoSmithKline1 trial
• Loxo Oncology, Inc.1 trial
• Novartis Pharma GmbH1 trial

Running trials

• Recruiting

  Study of Perioperative Dostarlimab in Participants With Untreated T4N0 or Stage III dMMR/MSI-H Resectable Colon Cancer

  NCT05855200· Phase 3· GlaxoSmithKline· Source

• Active, not recruiting

  Study of LOXO-305 (Pirtobrutinib) Versus Investigator's Choice (Idelalisib Plus Rituximab or Bendamustine Plus Rituximab) in Patients With Previously Treated Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)

  NCT04666038· Phase 3· Loxo Oncology, Inc.· Source

Closed trials

• Completed

  HU-F-AIM - A prospective, interventional clinical study to evaluate hydroxyurea (HU) resistance in patients with polycythaemia vera who meet prediction parameters identified in the PV-AIM project using artificial intelligence

  2022-502338-20-00· Phase 4· Novartis Pharma GmbH· Source